Search research articles
Contact Us
Filters
Showing results (71-80 of 85) with videos related to
Page
of 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1997
Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation
F M Michiels, S Chappuis, B Caillou, et al.
American Journal of Human Genetics
|
January 1, 1996
A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families
O Serova, M Montagna, D Torchard, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 25, 1994
Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid glands of transgenic mice
F M Michiels, B Caillou, M Talbot, et al.
Cancer Gene Therapy
|
November 1, 2001
BRCA1 carries tumor suppressor activity distinct from that of p53 and p21
V Randrianarison, D Marot, N Foray, et al.
Archives of Internal Medicine
|
September 13, 1993
DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study
H T Lynch, P Watson, T A Conway, et al.
Human Molecular Genetics
|
August 1, 1993
Genetic mapping of the breast-ovarian cancer syndrome to a small interval on chromosome 17q12-21: exclusion of candidate genes EDH17B2 and RARA
J Simard, J Feunteun, G Lenoir, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales
|
January 1, 1996
[Neural crest and multiple endocrinopathies]
A Pasini, F M Michiels, S Chappuis-Flament, et al.
Oncogene
|
October 1, 1994
Germ-line exclusion of a single p53 allele by premature termination of translation in a Li-Fraumeni syndrome family
M C Stolzenberg, L Brugières, M Gardes, et al.
American Journal of Human Genetics
|
April 1, 1993
A breast-ovarian cancer susceptibility gene maps to chromosome 17q21
J Feunteun, S A Narod, H T Lynch, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
June 27, 1997
Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies
M Chatelut, K Harzer, H Christomanou, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 85) with videos related to
Sort By:
Page
of 9
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1997
Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation
F M Michiels, S Chappuis, B Caillou, et al.
American Journal of Human Genetics
|
January 1, 1996
A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families
O Serova, M Montagna, D Torchard, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 25, 1994
Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid glands of transgenic mice
F M Michiels, B Caillou, M Talbot, et al.
Cancer Gene Therapy
|
November 1, 2001
BRCA1 carries tumor suppressor activity distinct from that of p53 and p21
V Randrianarison, D Marot, N Foray, et al.
Archives of Internal Medicine
|
September 13, 1993
DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study
H T Lynch, P Watson, T A Conway, et al.
Human Molecular Genetics
|
August 1, 1993
Genetic mapping of the breast-ovarian cancer syndrome to a small interval on chromosome 17q12-21: exclusion of candidate genes EDH17B2 and RARA
J Simard, J Feunteun, G Lenoir, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales
|
January 1, 1996
[Neural crest and multiple endocrinopathies]
A Pasini, F M Michiels, S Chappuis-Flament, et al.
Oncogene
|
October 1, 1994
Germ-line exclusion of a single p53 allele by premature termination of translation in a Li-Fraumeni syndrome family
M C Stolzenberg, L Brugières, M Gardes, et al.
American Journal of Human Genetics
|
April 1, 1993
A breast-ovarian cancer susceptibility gene maps to chromosome 17q21
J Feunteun, S A Narod, H T Lynch, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
June 27, 1997
Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies
M Chatelut, K Harzer, H Christomanou, et al.
Page
of 9